0.05). Yorum: Beklenen mortalite hızı ile yoğun bakım mortalitesinin benzer olduğunu gözledik. APACHE II skorlamasının SYBÜ'de mortalite hızının belirlenmesi ve tedavi etkinliğinin değerlendirilmesinde başarıyla kullanılabileceği kanısındayız. Aim: To compare observed and predicted mortality rate regarding to Acute Physiology and Chronic Health Evaluation (APACHE) II scores for cases followed in respiratory intensive care unit (RICU). Material and Methods: Prospectively collected data of 100 adults admitted to RICU because of acute respiratory failure (ARF) due to non-operative pulmonary disease were analyzed. The worst values of the physiological data in the first-RICU-day were used for calculations of APACHE II scores. Adjusted predicted mortality rate according to APACHE II scoring system was determined. Observed mortality rate in RICU was recorded. Results: Mean age of cases (68 male/32 female) was 58.1 ± 15.4 years. 67% of cases had chronic obstructive pulmonary disease (COPD). Mean APACHE II score was calculated as 27.4 ± 7.9. Compared with survivors APACHE II score was significantly higher in nonsurvivors (25.2 ± 7.9 versus 30.4 ± 7.1) (p< 0.05). Observed mortality rate in RICU was 41% while predicted was 48.6% and the difference was not statistically significant (p> 0.05). Conclusion: APACHE II-predicted mortality rate and RICU mortality were similar in our analysis. We thought that APACHE II scoring system could be used successfully in predicting mortality rate and evaluating efficacy of treatment in RICU.">
[PDF] APACHE II skorlama sistemi solunumsal yoğun bakım ünitesinde mortalite hızını belirlemede başarılı mıdır? | [PDF] Is APACHE II scoring system successfull to determine mortality rate in respiratory intensive care unit?
0.05). Yorum: Beklenen mortalite hızı ile yoğun bakım mortalitesinin benzer olduğunu gözledik. APACHE II skorlamasının SYBÜ'de mortalite hızının belirlenmesi ve tedavi etkinliğinin değerlendirilmesinde başarıyla kullanılabileceği kanısındayız.">
0.05). Yorum: Beklenen mortalite hızı ile yoğun bakım mortalitesinin benzer olduğunu gözledik. APACHE II skorlamasının SYBÜ'de mortalite hızının belirlenmesi ve tedavi etkinliğinin değerlendirilmesinde başarıyla kullanılabileceği kanısındayız. Aim: To compare observed and predicted mortality rate regarding to Acute Physiology and Chronic Health Evaluation (APACHE) II scores for cases followed in respiratory intensive care unit (RICU). Material and Methods: Prospectively collected data of 100 adults admitted to RICU because of acute respiratory failure (ARF) due to non-operative pulmonary disease were analyzed. The worst values of the physiological data in the first-RICU-day were used for calculations of APACHE II scores. Adjusted predicted mortality rate according to APACHE II scoring system was determined. Observed mortality rate in RICU was recorded. Results: Mean age of cases (68 male/32 female) was 58.1 ± 15.4 years. 67% of cases had chronic obstructive pulmonary disease (COPD). Mean APACHE II score was calculated as 27.4 ± 7.9. Compared with survivors APACHE II score was significantly higher in nonsurvivors (25.2 ± 7.9 versus 30.4 ± 7.1) (p< 0.05). Observed mortality rate in RICU was 41% while predicted was 48.6% and the difference was not statistically significant (p> 0.05). Conclusion: APACHE II-predicted mortality rate and RICU mortality were similar in our analysis. We thought that APACHE II scoring system could be used successfully in predicting mortality rate and evaluating efficacy of treatment in RICU.">
Ulaşmaya çalıştığınız dergi veri tabanımızda bulunmamaktadır. Detaylı bilgi için lütfen editörle iletişime geçiniz, acarindex@gmail.com